

Cover Story
By Matthew Bin Han Ong
Responding to removal of its Medicare “deemed status,” MD Anderson Cancer Center has submitted a “plan of correction” to the Texas Health and Human Services Commission to demonstrate that it is now in compliance with all federal requirements for participation in the Medicare program.
In Brief
Funding Opportunities
Clinical Roundup
Drugs & Targets


Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- Jonathan Licht named president, chief scientific officer at Van Andel Institute
- Friends publishes three white papers ahead of annual meeting
Topics: Clinical trials on rare cancers, combination drug trials, multi-regional studies - Early endpoints are a balance of risk and benefit















